Phase I-II-III-IV Clinical Trial

Leading Global Clinical Development Programs

Omega has deep expertise in facilitating Phase II-IV clinical trials for new drugs, biologics, and medical devices. We help sponsors with multiple clinical development challenges in global clinical programs through strong clinical operation capability. Our international experience enables you to optimize clinical operations to reduce risk and lower costs.

Comprehensive Early Research, Design, & Execution Expertise

•Phase IIa, proof-of-concept

•Clinical PK/PD

•Bioanalytical and biomarkers

•Bioequivalence studies